ArticleUpdates in surgery2026
Single-port robotic system approach for pulmonary lobectomy: our technique and preliminary results.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study evaluates safety of SP robotic anatomic lung resection for primary lung cancer, and the perioperative outcomes in our early clinical experience. From March 2025 to March 2026, 14 consecutive patients with lung cancer underwent SP robotic lobectomy and systematic lymphadenectomy using da Vinci SP system via subcostal approach. All 14lobectomies (7 right upper, 5 right lower, and 2 middle lobectomy) were completed without conversion or intraoperative complications. Median operative time was 176 min (120-220 min). Twelve patients had adenocarcinoma with pathological stage IA1 in 4 (33.3%) patients, IA2 in 4 (33.3%) patients and stage IB in 4 (33.3%) patients; two patients had typical carcinoid tumor with pathological stage IB. No postoperative complications occurred. Median chest tube duration was 2 days (range 2-6), with median hospital stay of 3 days (3-7). SP robotic lung resection using da Vinci SP system via a subcostal approach demonstrates feasibility, safety, and favorable perioperative outcomes as well as adequate lymphadenectomy. Further multi-institutional studies with longer oncologic follow-up are needed.
Indexed as
Identifiers
42745095What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.